Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus?
Dear Sir, The paper by Chico et al. argues that an increased albumin excretion rate (AER), rather than creatinine clearance, influences plasma homocysteine concentrations in diabetic patients [1] . In our view, their conclusions are not fully validated by the data they present. Firstly, looking at Figure 1 , the differences in homocysteine concentrations in patients with Type I (insulin-dependent) and Type II (non-insulin-dependent) diabetes mellitus with varying degrees of albuminuria are not statistically significant, as long as patients with high serum creatinine concentrations (> 120 umol/l) are excluded. Nowhere is it shown that microalbuminuric patients have statistically significantly higher homocysteine concentrations than patients with normoalbuminuria. Only when Type I and Type II diabetic patients are taken together, do macroalbuminuric patients have higher homocysteine concentrations than normoalbuminuric patients. Differences in Cockroft-Gault derived creatinine clearances are not given for this combined group but the subgroups show progressively lower clearances in patients with micro-and macroalbuminuria. That these differences are not statistically significant does not rule out that they influence homocysteine concentrations. Why are the non-significant differences in creatinine clearance judged as irrelevant, whereas the equally non-significant differences in homocysteine concentrations are interpreted as important results?
The multivariate analysis of determinants of homocysteine concentrations suggests that neither B-vitamin concentrations nor creatinine clearance but only albumin excretion rate (and age in Type II diabetes) influence homocysteine concentrations in the diabetic subgroups. It is generally accepted that the maximum number of variables in a multiple regression model, stepwise or not, should never be more than 10 % and preferably less than 5 % of the number of patients. Since the authors state that`all variables' were included, it appears that around 15 variables were used in models with 75 (Type I) and 90 (Type II) patients. This makes the analyses unstable, and prone to spurious results.
The most important potential source of error is that determinants and complications of increasing homocysteine concentrations could have been mixed-up. Albuminuria is seen more often in the presence of cardiovascular risk factors, like hypertension, smoking, obesity, and dyslipidaemia. It is certainly plausible that the`new' vascular risk factor hyperhomocysteinaemia causes albuminuria, rather than the other way round. If this is so, then a complication of increasing homocysteine concentrations is analysed as a co-variate of determinants of these concentrations, which leads to erroneous results. In contrast with the situation of bivariate tests, the set-up of a multiple regression analysis automatically introduces assumptions about the direction of causality between the independent and the dependent variable. We would like to invite the authors to produce the results of a more logical model with albumin excretion rate as the dependent variable and homocysteine as one of the independent variables, together with other known determinants of albuminuria.
The vast majority of studies in both diabetic and non-diabetic subjects has found creatinine clearance to be an important determinant of homocysteine concentrations. The results are certainly more equivocal for albuminuria. The central question of whether there is a relation between albumin excretion rate and homocysteine concentrations, independent of creatinine clearance, remains unresolved.
Yours sincerely, Y. M. Smulders, C. B. Brouwer, J. Silberbusch
